Graft Polymer (UK) - Admission & Director/PDMR Shareholding
10/07/2024 08:10
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240710:nRSJ7400Va&default-theme=true
RNS Number : 7400V Graft Polymer (UK) PLC 10 July 2024
10 July 2024
Graft Polymer (UK) Plc
(the "Company")
Admission, PDMR share dealings
and
Total Voting Rights
Further to the Company's announcement of 3 July 2024, the Company announces
that a total of 2,171,166,667 new Ordinary Shares, including the
1,800,000,000 Placing Shares, have been admitted to trading on the Main Market
of the London Stock Exchange and to listing on the Standard Segment of the
FCA's Official List this morning.
Notifications required by UK MAR are set out below.
Total Voting Rights
Following Admission, the Company's issued ordinary share capital consists of
2,295,930,633 Ordinary Shares with one voting right each. The Company does not
hold any Ordinary Shares in treasury. Therefore, the total number of Ordinary
Shares and voting rights in the Company is 2,295,930,633. This figure may be
used by shareholders in the Company as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's Disclosure Guidance
and Transparency Rules.
Capitalised terms in this announcement shall have the meanings ascribed to
them in the Company's announcement of 3 July 2024 unless stated otherwise.
Enquiries:
Graft Polymer (UK) Plc:
Anthony Tennyson, CEO and Executive Director: anthonytennyson@graftpolymer.com
(mailto:anthonytennyson@graftpolymer.com)
Yifat Steuer, CFO and Executive Director: yifat@graftpolymer.com
(mailto:yifat@graftpolymer.com)
Allenby Capital (Broker):
Phone: +44 (0) 20 3328 5656
Nick Naylor / Liz Kirchner / James Reeve (Corporate Finance)
Guy McDougall (Sales)
About Graft Polymer (UK) Plc
Graft Polymer (UK) Plc (LSE: GPL) is an innovative developer of biopolymer
drug delivery systems dedicated to assisting biopharmaceutical companies in
enhancing the effectiveness of their therapeutics. Our proprietary patented
platform, a bioabsorbable self-nanoemulsifying drug delivery system (SNEDDS),
represents a cutting-edge solution in drug delivery technology. By integrating
active pharmaceutical ingredients (APIs) into our novel, patented delivery
systems, we enable clients to improve the bioavailability, pharmacokinetics,
and stability of their therapeutics.
Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Nicholas Nelson
2. Reason for the Notification
a) Position/status Director
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Graft Polymer (UK) plc
b) LEI 2138005PH7OJRCRPUD88
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares:
GB00BMD1Z199
b) Nature of the transaction Placing Participation
c) Price(s) and volume(s) Price(s) Volume(s)
0.1 pence per share 25,000,000
d) Aggregated information: n/a
-Aggregated volume
-Price
e) Date of the transaction 10 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information:
-Aggregated volume
-Price
n/a
e)
Date of the transaction
10 July 2024
f)
Place of the transaction
Outside of a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Nicholas Nelson
2. Reason for the Notification
a) Position/status Director
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Graft Polymer (UK) plc
b) LEI 2138005PH7OJRCRPUD88
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares:
GB00BMD1Z199
b) Nature of the transaction Loan Conversion Shares
c) Price(s) and volume(s) Price(s) Volume(s)
0.1 pence per share 132,000,000
d) Aggregated information:
-Aggregated volume n/a
-Price
e) Date of the transaction 10 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information:
-Aggregated volume
-Price
n/a
e)
Date of the transaction
10 July 2024
f)
Place of the transaction
Outside of a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1) Nicholas Nelson
2) Pavel Kobzev
3) Yifat Steuer
2. Reason for the Notification
a) Position/status Directors
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Graft Polymer (UK) plc
b) LEI 2138005PH7OJRCRPUD88
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares:
GB00BMD1Z199
b) Nature of the transaction Issuance of Fee Shares
c) Price(s) and volume(s) Price(s) Volume(s)
1) 0.1 pence per share 10,500,000
2) 0.1 pence per share 10,000,000
3) 0.1 pence per share 10,000,000
d) Aggregated information: n/a
-Aggregated volume
-Price
e) Date of the transaction 10 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information:
-Aggregated volume
-Price
n/a
e)
Date of the transaction
10 July 2024
f)
Place of the transaction
Outside of a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1) Victor Bolduev
2) Yifat Steuer
3) Pavel Kobzev
2. Reason for the Notification
a) Position/status Directors
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Graft Polymer (UK) plc
b) LEI 2138005PH7OJRCRPUD88
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares:
GB00BMD1Z199
b) Nature of the transaction Issuance of Management Shares
c) Price(s) and volume(s) Price(s) Volume(s)
1) 0.6 pence per share 22,529,166
2) 0.6 pence per share 11,711,167
3) 0.6 pence per share 8,694,000
d) Aggregated information: n/a
-Aggregated volume
-Price
e) Date of the transaction 10 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information:
-Aggregated volume
-Price
n/a
e)
Date of the transaction
10 July 2024
f)
Place of the transaction
Outside of a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name Nicholas Nelson
2. Reason for the Notification
a) Position/status Director
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Graft Polymer (UK) plc
b) LEI 2138005PH7OJRCRPUD88
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares:
GB00BMD1Z199
b) Nature of the transaction Grant of Lender Warrants
c) Price(s) and volume(s) Exercise Price(s) Volume(s)
0.1 pence per share 132,000,000
d) Aggregated information: n/a
-Aggregated volume
-Price
e) Date of the transaction 10 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information:
-Aggregated volume
-Price
n/a
e)
Date of the transaction
10 July 2024
f)
Place of the transaction
Outside of a trading venue
1. Details of the person discharging managerial responsibilities / person closely
associated
a) Name 1) Nicholas Nelson
2) Yifat Steuer
2. Reason for the Notification
a) Position/status Directors
b) Initial notification/Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Graft Polymer (UK) plc
b) LEI 2138005PH7OJRCRPUD88
4. Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Ordinary shares of £0.001 each
Identification code Identification code (ISIN) for Graft Polymer (UK) plc ordinary shares:
GB00BMD1Z199
b) Nature of the transaction Grant of Director Warrants
c) Price(s) and volume(s) Exercise Price(s) Volume(s)
1) 0.1 pence per share 10,500,000
2) 0.1 pence per share 20,000,000
d) Aggregated information: n/a
-Aggregated volume
-Price
e) Date of the transaction 10 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information:
-Aggregated volume
-Price
n/a
e)
Date of the transaction
10 July 2024
f)
Place of the transaction
Outside of a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBUGDRLGGDGSC
Recent news on Solvonis Therapeutics
See all newsBrief: Solvonis Therapeutics Plans IND Submission For Phase 2B Trial Of SVN-2 In U.S.
Solvonis Therapeutic - Announces Positive Bridging Data Supporting
Solvonis Therapeutic - Notice of Annual General Meeting
RCS - Solvonis Therapeutic - CSO Speaks at National Research Meeting
Solvonis Therapeutic - Final Results